Table 2. Cox regression analysis of prognostic factors for overall CRC patient survival (n=188).
Clinicopathological features | Univariate Analysis | Multivariate Analysis | ||
---|---|---|---|---|
HR (95%Cl) | P-value | HR (95%Cl) | P-value | |
miR-138-5p downregulation | 0.466(0.274-0.790) | 0.001* | 0.493(0.273-0.890) | 0.019* |
Gender | 0.688(0.402-1.176) | 0.535 | ||
Age | 0.677(0.465-1.241) | 0.688 | ||
T status | 1.605(0.969-2.658) | 0.066 | 1.561(0.951-2.564) | 0.078 |
Lymph node metastasis | 1.990(1.393-2.841) | <0.001* | 1.831(1.296-2.587) | 0.001* |
M status | 2.819(1.632-4.869) | <0.001* | 2.65(2.015-4.542) | <0.001* |
TNM stage | 2.623(1.959-3.512) | <0.001* | 2.004(1.384-2.901) | <0.001* |
Dukes stage | 2.793(2.093-3.728) | <0.001* | 2.113(1.492-2.992) | <0.001* |
CI = confidence interval; HR = hazard ratio
P<0.05.